This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n12http://linked.opendata.cz/resource/drugbank/drug/DB04678/identifier/pdb/
n8http://bio2rdf.org/drugbank:
n13http://linked.opendata.cz/resource/drugbank/drug/DB04678/identifier/pubchem-compound/
admshttp://www.w3.org/ns/adms#
n9http://linked.opendata.cz/resource/drugbank/drug/DB04678/identifier/pubchem-substance/
n11http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n4http://linked.opendata.cz/resource/drugbank/drug/DB04678/identifier/drugbank/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n5http://linked.opendata.cz/ontology/drugbank/
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB04678
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n8:DB04678 n11:DB04678
dcterms:title
H TYPE II TRISACCHARIDE
adms:identifier
n4:DB04678 n9:46508022 n12:DR2 n13:5288910
n5:IUPAC-Name
n6:271B490F-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B4915-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B4914-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B4911-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B4912-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B4913-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B490D-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B490E-363D-11E5-9242-09173F13E4C5 n6:271B490B-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B490C-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B491B-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B491C-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B4916-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B4917-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B4919-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B4918-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B491A-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B4921-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B4923-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B4924-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B4920-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B491F-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B4922-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B4910-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B491D-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B491E-363D-11E5-9242-09173F13E4C5